Floatz logo

Pumvc3-Higfbp-2 Multi-Epitope Plasmid Dna Vaccine

Stage III Ovarian Germ Cell Tumor

University of WashingtonvaccinePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
31/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Stage III Ovarian Germ Cell Tumor cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Nabil Adra
Phase 3BB
Carboplatin
Case Comprehensive Cancer Center
Phase 2BB
CIS-DIAMMINEDICHLOROPLATINUM II
Children's Oncology Group
Phase 3BB
Eloxatin
National Cancer Institute (NCI)
Phase 2BB
BLEOMYCIN
Children's Oncology Group
Phase 3BB

View all 44 →

Same molecule, other indications

Pumvc3-Higfbp-2 Multi-Epitope Plasmid Dna Vaccine is also rated in:

ovarian carcinomaDormant
CCC
Indicative ·
54 / 100
View asset →
Fallopian Tube CarcinomaDormant
CCC
Indicative ·
50 / 100
View asset →
primary peritoneal carcinomaDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →